A carregar...
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277650/ https://ncbi.nlm.nih.gov/pubmed/30519347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27342 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|